Evolving shifts in otitis media pathogens: Relevance to a managed care organization

American Journal of Managed Care

Volumn 11, Issue 6 SUPPL., 2005, Pages

  Pichichero, Michael E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; HEALTH INSURANCE; HUMAN; INFANT; MICROBIOLOGY; OTITIS MEDIA; PRESCHOOL CHILD; PUBLICATION; UNITED STATES;

ACUTE DISEASE; CHILD, PRESCHOOL; FORMULARIES; HUMANS; INFANT; MANAGED CARE PROGRAMS; OTITIS MEDIA; UNITED STATES;

EID: 32944467480     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Dagan R. Treatment of AOM : challenges in the era of antibiotic resistance. Vaccine. 2001; 19: S9-S16. (Pubitemid 33714397)
2. Block SL, Hedrick J, Harrison CJ et al. Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 2002; 21: 859-865.
3. Wald ER, Mason BO Jr, Bradley JS Barson WJ Kaplan SL Acute otitis media caused by Sreptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J 2001; 20: 34-39.
4. Pelton SI, Klein JO. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr Infect Dis J 1999; 18: 926-935. (Pubitemid 29487517)
5. Block SL, Harrison CJ, Hedrick JA, et al. Penicillinresistant Sreptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14: 751-759.
6. Rodriguez WJ, Schwartz RH, Akram S, Khan WN. Sreptococcus pneumoniae resistant to penicillin: incidence and potential therapeutic options. Laryngoscope. 1995; 105: 300-304.
7. Berman S. Otitis media in children. N Engl J Med. 1995; 332: 1560-1565.
8. Freld VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principa diagnosis and place of visit. Vital Health Stat 13. 1998; (137): 1-23.
9. Marcy M, Takata G, Shekelle P, et al. Management of Acute Otitis Media. Evidence Report/Technology Assessment No.15 (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-97-0001). AHRQ Publication No. 01-B310. Rockville, Md: Agency for Healthcare Research and Quaity, 2001.
10. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000; 105: E72.
11. What is a dollar worth? Federal Reserve Bank of Minneapolis. Available at: http://minneapolisfed.org/ Research/data/us/calc/index.cfm. Accessed May 6, 2005.
12. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11(suppl 8): S7-S11.
13. Johnson CE, Carlin SA, Super DM, et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr. 1991; 119: 117-122.
14. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992; 120: 81-84.
15. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis. 1985; 4: 641-646.
16. JacobsMR,DaganR,AppelbaumPC,BurchDJ.Prevalenceofantimicrobial- resistantpathogensinmiddleearfluid: multinationalstudyof917childrenwithacuteotitismedia.AntimicrobAgentsChemother. 1998;42:589-595.(Pubitemid28114813)
17. Block SL, Hedrick JA, Tyler RD, Smith RA, Harrison CJ. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr Infect Dis J 2001; 20: 1017-1021.
18. Duchin JS, Brei man RF, Diamond A, et al. High prevalence of multidrug-resistant Sreptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14: 745-750.
19. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern Caliifornia Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187-195.
20. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003; 22: 10-16. (Pubitemid 36091771)
21. Casey JR, Rchichero ME Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23: 824-828.
22. Block SL, Hedrick J, Harrison CJ, et al. Communitywide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23: 829-833. (Pubitemid 40221025)
23. Gehanno P, N'Guyen L, Derriennic M, Pichon F, Goehrs JM, Berche P. Pathogens isolated during treatment failuresin otitis Pediatr Infect DisJ 1998; 17: 885-890. (Pubitemid 28506409)
24. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Sreptococcus pneumoniae in children with acute otitis media in Ssain. Pediatr Infect Dis J 1998; 17: 94-97. (Pubitemid 28096004)
25. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J 1998; 17: 463-469. (Pubitemid 28287609)
26. Physician's Desk Reference (electronic version). Greenwood Village, Colo: Thomson MICRO MED EX; 2005.
27. Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D. Acute otitis media caused by antibiotic-resistant Sreptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines J Infect Dis 2000;181:1322-1329. (Pubitemid 30252536)
28. Jbloba ML, Windau A, Bajaksouzian Si, et al. Pneumococcal conjugate vaccine serotypes of Sreptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001; 33: 1489-1494. (Pubitemid 34246141)
29. Block SL, Hedrick JA, Harrison CJ. Widespread use of conjugated pneumococcal vaccine significantly reduces rates of AOM and antibiotic usage. Abstract #1135. Pediatr Res 2004; 55(suppl): 201A.
30. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001; 344: 403-409. (Pubitemid 32128672)
31. Centers for Disease Control. National, state, and urban area vaccination coverage among children aged 19-35 months-United Sates, 2003. MMWR Morb Mortal Wkly Rep. 2004; 53: 658-661.
32. CentersforDiseaseControl. Updatedrecommendationsforuseofpneumococcalconjugatevaccine: reinstatementofthethirddose.MMWRMorbMortalWklyRep.2004;53:589-590. (Pubitemid43236477)
33. Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003; 37: 1155-1164.
34. Dowell SF, Butler X, Giebink GS. Acute otitis media: management and surveillance in an era of pneumococcal resistance. Drug-Resistant Sreptococcus Pneumoniae Therapeutic Working Group. Nurse Pract. 1999; 24(suppl 10): 1-9.
35. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA 1993; 270: 1344-1351.
36. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003; 348: 1737-1746. (Pubitemid 36514704)
37. Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004; 23: 485-489. (Pubitemid 38802290)
38. Klugman KP, Madhi SA, Huebner RE, et al. A tria of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003; 349: 1341-1348.
39. DowellSF,MarcySM,PhilipsWR,GerberMA,SchwartzB.Otitismedia- principlesofjudicioususeofantimicrobialagents.Pediatrics.1998;101(suppl): 165-171.(Pubitemid28027853)
40. Garbutt J, Jeffe DB, Shackelford P. Diagnosis and treatment of acute otitis media: an assessment. Pediatrics 2003; 112: 143-149. (Pubitemid 36792942)
41. ListerPD,PongA,ChartrandSA,SandersCC.Rationalebehindhigh- doseamoxicillintherapyforacuteotitismediadue-penicillin- nonsusceptiblepneumococci: supportfrominvitropharmacodynamicstudiesAntimicrobAgentsChemother.1997;41: 1926-1932.(Pubitemid27383229)
42. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J 2003; 22: 405-413.
43. Palmer DA, Bauchner H. Parents' and physicians' views on antibiotics Pediatrics. 1997; 99: E6.
44. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1997; 16: 710-711. (Pubitemid 27300710)
45. Dowell SF, Butler JC, Giebink GS. et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Sreptococcus Pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1-9.
46. American Academy of Pediatrics Subcommittee on Management. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451-1465.
47. Dagan R, Johnson CE, McLinn S. et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000; 19: 95-104. (Pubitemid 30111402)
48. Patel JA, Reisner B, Vizirinia N, Owen M, Chonmaitree T, Howie V. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr. 1995; 126: 799-806.
49. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media Pediatr Infect Dis J 2001; 20: 829-837. (Pubitemid 32880315)
50. Hoberman A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacteria acute otitis media in children. Pedatr Infec Dis J 2005; 24: 525-532. (Pubitemid 40847526)
51. Howie VM. Eradication of bacteria pathogens from middle ear infections. Clin Infect Dis. 1992; 14(suppl 2): 209-211.
52. DaganR,AbramsonO,LeibovitzE,etal.Bacteriologicresponse- oralcephalosporins: areestablishedsusceptibilitybreakpointsappropriateinthecaseofacuteotitismedia? JInfectDis.1997;176:1253-1259.(Pubitemid27460991)
53. Brook I. Use of oral cephalosporins in the treatment of acute otitis media in children. Int J Antimicrob Agents. 2004; 24: 18-23. (Pubitemid 38844556)
54. Jacobs MR, Bajaksouzian S, ZillesA, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Sreptococcus pneumoniae and Haemophilus influenzae to 10 ora antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance Sudy. Antimicrob Agents Chemother. 1999; 43: 1901-1908.
55. Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters Clin Microbiol Infect. 2001; 7: 589-596.
56. Jacobs MR, Bajaksouzian S, Windau A, et al. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 ora antimicrobial agents based on pharmacodynamic parameters: 1998-2001 US Surveillance Sudy. Clin Lab Med. 2004; 24: 503-530.
57. KleinJO.Microbiologicefficacyofantibacterialdrugsforacuteotitismedia. PediatrInfectDisJ1993;12:973-975.(Pubitemid23360865)
58. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponave acute otitis media. Pediatr Infect Dis J 1998; 17: 1126-1131. (Pubitemid 29023887)
59. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J 2000; 19: 1040-1045.
60. Rchichero ME A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005; 115: 1048-1057.
61. EdnieLM,VisalliMA,JacobsMR,AppelbaumPC. Comparativeactivitiesofclarithromycin,erythromycin, andazithromycinagainstpenicillin-susceptibleandpenicillin-reastantpneumococci. AntimicrobAgentsChemother.1996;40:1950-1952.(Pubitemid26277825)
62. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests (M100-S8). Villanova, Pa: National Committee for Clinical Laboratory Sandards, 1998.
63. Olson LC, Jackson MA. Only the pneumococcus. Pediatr Infect Dis J 1999; 18: 849-850.
64. Rodriguez WJ, Schwartz RH. Sreptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J 1999; 18: 942-944.
65. Heikkinen T, Ghaffar F, Okorodudu AO, Chonmaitree T. Serum interleukin-6 in bacteria and nonbacterial acute otitis media Pediatrics. 1998; 102: 296-299. (Pubitemid 28354992)
66. Broides A, Leibovitz E, Dagan R, et al. Cytology of middle ear fluid during acute otitis media. Pediatr Infect Dis J 2002; 21: 57-61.
67. McCormick DP, Lim-Melia E, Saeed K, Baldwin CD, Chonmaitree T. Otitis media: can clinical findings predict bacteria or viral etiology? Pediatr Infect Dis J 2000; 19: 256-258. (Pubitemid 30167452)
68. Leibovitz E, Satran R, Piglansky L, et al. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J 2003; 22: 509-515.
69. Bahadori RS, Schwartz RH, Ziai M. Acute mastoiditis in children: an increase in frequency in Northern Virginia. Pediatr Infect Dis J 2000; 19: 212-215. (Pubitemid 30167440)
70. Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditisin Southern Israel: a twelve year retrospective study (1990 through 2001). Pediatr Infect Dis J 2003; 22: 878-882. (Pubitemid 37288610)
71. Luntz M, Brodsky A, Nusem S, et al. Acute mastoiditis-the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001; 57: 1-9.
72. Tarantino V, D'Agostino R. Taborelli G, Melagrana A, Porcu A, Stura M. Acute mastoiditis: a 10 year retrospective study. Int J Pediatr Otorhinolaryngol. 2002; 66: 143-148. (Pubitemid 35266871)